Hanne Callewaert (PhD) is co-founder and CEO of AstriVax. She has 20+ years of experience in the life sciences through a PhD in Medical Sciences, Masters in IP, followed by global industry experience in GSK Vaccines as well as into smaller biotech environment, like Oxurion, Oncurious and AstriVax.  She has a strong background in regulatory affairs, drug and vaccine development expertise blended with business and corporate development through executive leadership functions as Chief Operating Officer at Oxurion, followed by her current CEO position at AstriVax. She has been involved in development of commercial, late or early stage vaccines, monoclonal antibodies, peptides and small molecules.